Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Robert W. Baird 

Ocular Therapeutix Inc. diskutieren

Ocular Therapeutix Inc.

WKN: A1180P / Symbol: OCUL / Name: Ocular / Aktie / Ausrüstung & Versorgung / Small Cap /

9,40 €
22,06 %

26 2
26
2
Einschätzung Buy
Rendite (%) -30,95 %
Kursziel 18,03
Veränderung
Endet am 09.12.26

Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat

Chardan Capital 
0
Melden Teilen
09.12.25

Ocular Therapeutix (NASDAQ:OCUL) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Ratings data for OCUL provided by MarketBeat

Royal Bank of Canada 
0
Melden Teilen
05.02.26 Buy 14,47 %

Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Ratings data for OCUL provided by MarketBeat

Jefferies Financial Group Inc. 
0
Melden Teilen
17.02.26 Buy 70,25 %

Ocular Therapeutix (NASDAQ:OCUL) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for OCUL provided by MarketBeat

Citigroup Inc. 
0
Melden Teilen
17.02.26 Buy 59,45 %
Einschätzung Buy
Rendite (%) 55,91 %
Kursziel 17,73
Veränderung
Endet am 18.02.27

Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat

Chardan Capital 
0
Melden Teilen
18.02.26
Einschätzung Buy
Rendite (%) 50,56 %
Kursziel 15,31
Veränderung
Endet am 20.02.27

Ocular Therapeutix (NASDAQ:OCUL) had its price target lowered by analysts at Needham & Company LLC from $20.00 to $18.00. They now have a "buy" rating on the stock.
Ratings data for OCUL provided by MarketBeat

Needham & Company LLC 
0
Melden Teilen
20.02.26

Ocular Therapeutix (OCUL) had its "outperform" rating reaffirmed by William Blair.
Ratings data for OCUL provided by MarketBeat

William Blair 
0
Melden Teilen
19:15 Buy 3,05 %
Noch kein Mitglied? Jetzt kostenlos registrieren!

Neueste Beiträge

Jefferies_Financial_ in Aerovironment diskutieren
AeroVironment (AVAV) had its "buy" rating reaffirmed by J...
23:00
BWS_Financial in Trimas Corp. diskutieren
TriMas (TRS) had its "buy" rating reaffirmed by BWS Finan...
22:15
Barrington_Research in Cra International Inc. diskutieren
Charles River Associates (CRAI) had its "outperform" rati...
22:15
UBS_Group_AG in Tutor Perini Corp. diskutieren
Tutor Perini (TPC) had its price target raised by UBS Gro...
22:15
UBS_Group_AG in Hannon Armstrong diskutieren
HA Sustainable Infrastructure Capital (HASI) had its pric...
22:15
DA_Davidson in Arcosa Inc diskutieren
Arcosa (ACA) had its price target raised by DA Davidson f...
21:30
Canaccord_Genuity_Gr in Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) had its price target lowere...
20:30
Cantor_Fitzgerald in Sterling Con diskutieren
Sterling Infrastructure (STRL) had its price target raise...
20:30
Mehr anzeigen